Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Capecitabine
Capecitabine
Routinely available
Local application
29/03/2023
Indication
Adjuvant treatment following potentially curative resection of pancreatic cancer.
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available in line with local guidance for prescribing
Formulation
gemcitabine powder for infusion and capecitabine tablets
Comments
-